LabCompass

Uma Borate

Medicine · The Ohio State University

Mid career · publishing since 2008Rising activity

Publications

292

Citations

8,016

Est. group size

~34

Recurring co-author estimate

Active years

19

Publishing since 2008

Research summary
AI-generated

Uma Borate is a physician-researcher focused on blood cancers, especially acute myeloid leukemia (AML, a fast-growing cancer of blood-forming cells) and myelodysplastic syndromes (MDS, disorders where the bone marrow fails to make healthy blood cells). Their work centers on running and reporting clinical trials that test new drugs and drug combinations, often targeting specific genetic mutations (like FLT3, IDH1/2, TP53, NPM1) found in these diseases, as well as efforts to standardize diagnosis and improve access to clinical trials for patients.

Acute myeloid leukemia (AML) drug trialsMyelodysplastic syndromes (MDS) researchTargeted therapies for genetic mutations in leukemiaCombination chemotherapy and novel agent trialsClinical trial design and access standardization

Publication output has grown substantially over the last decade, rising from single digits in 2017 to over 80 in 2025, indicating an accelerating and currently very active publication pace.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026

Publication cadence
Publications per year over the last 10 years — averaging 33.0/year recently
2017: 4 publications172018: 16 publications182019: 14 publications192020: 12 publications202021: 36 publications212022: 28 publications222023: 21 publications232024: 32 publications242025: 81 publications81252026: 3 publications26
Recent publications
Publishes in
  • Blood×100
  • Clinical Lymphoma Myeloma & Leukemia×26
  • Blood Advances×12
  • Journal of Clinical Oncology×12
  • HemaSphere×4
Similar researchers
By research-topic overlap

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 19, 2026.

Claim or correct this profile